In a recent LinkedIn post, Dr. Martha Boeckenfeld explores the complex ethical and personal questions arising from advancements in predictive health technology, particularly concerning genetic data and digital twins. Dr. Boeckenfeld frames her insights around a personal experience undergoing an MRI scan aimed at detecting early markers for neurodegeneration and cancer.
The experience prompted a profound reflection on the implications of knowing potential future health risks years before symptoms manifest. Dr. Boeckenfeld writes:
Would I actually want to know what might be happening inside me 10 to 15 years before I feel a symptom?
This central question underscores the tension between the desire for foreknowledge and the psychological burden it can impose. Dr. Boeckenfeld acknowledges the fear associated with such scans, especially when family history suggests a predisposition to serious illnesses.
Challenging Genetic Determinism
Dr. Boeckenfeld challenges the notion that genetic makeup dictates an unalterable fate. She highlights the role of epigenetics in influencing gene expression, suggesting that biological destiny is not a fixed countdown.
As Dr. Boeckenfeld notes:
Epigenetic marks affect which genes are switched on. Those marks can change. Biology is not always a fixed countdown.
This perspective offers a more nuanced view of health, emphasizing that while genetic predispositions exist, they are not necessarily definitive. The ability to understand and potentially influence these epigenetic marks provides a crucial window for proactive health management.
The Power of Early Information
According to Dr. Boeckenfeld, knowing about a health risk earlier, even if it doesn’t immediately prevent a disease, provides valuable time for decision-making. This extended period allows individuals to explore options and make informed choices before their health circumstances significantly narrow their choices.
She elaborates on this point:
Knowing about a risk earlier does not stop a disease. It gives you more time to decide what to do before your options narrow.
This insight is critical for reframing the purpose of predictive diagnostics, shifting the focus from passive nhận thức of risk to active engagement with potential health futures.
The Uncharted Territory of Digital Twins and Data Ownership
Beyond the personal implications, Dr. Boeckenfeld raises significant ethical questions regarding the ownership and accessibility of evolving digital health models, or ‘computational twins’. As our biological data is increasingly modeled and analyzed, the ownership of these digital representations becomes a pressing concern.
Dr. Boeckenfeld poses critical questions about the future:
Who owns your computational twin as it changes over time? Who gets access if a model can forecast disease years before symptoms appear? And how do we keep this kind of care from becoming something only wealthy patients can afford?
These questions probe the potential for a future where advanced health insights and interventions are stratified by socioeconomic status. Dr. Boeckenfeld’s concerns highlight the need for robust ethical frameworks and equitable access policies to ensure that technological advancements in healthcare benefit society broadly, rather than exacerbating existing inequalities.
Her full argument, as she mentions, is detailed in her work, “The End of Guesswork: Why Your Genes Are Not Your Destiny.” Dr. Boeckenfeld’s post serves as a powerful call to consider the profound personal and societal implications of predictive health technologies as they continue to evolve.
📝 About This Content
This article is based on insights shared by Dr. Martha Boeckenfeld on LinkedIn.
📅 Originally posted on September 7, 2026 | View original post on LinkedIn →